Abstract:Objective To evaluate the utility of N-terminal proBNP(NT-proBNP)measurement in identifying impaired cardiac function in patients in medical conditions. Methods 95 patients were included. One or two cardiologist evaluated the patients in terms of history, physical examination, echocardiography and suspicion of heart failure. All the patients were classified into three groups: group A (normal cardiac function), group B (diastolic dysfunction), group C (systolic and/or diastolic dysfunction). Plasma NT-proBNP level was measured by the Roch NT-proBNP electrochemiluminescent assay. Results In the un divided sample, NT-proBNP levels were significantly associated with LV end diastolic dimension (r=0.54,P=0.0016), LA end diastolic dimension(r=0.49,P=0.0016), LVEF(r=0.59,P=0.0015), but had no close relation to age. The male patients' mean NT-proBNP level (945±3238.2 mL/pg) was unsignificantly(P=0.06) higher than female patients'(722.0±1414.2)pg/mL. The patients in Group B and group C had significantly increased NT-proBNP levels mean level(128.6±194.8)pg/mL, (2496.2±4054.0)pg/mL, respectively compared to patients of group A (39.6± 46.1)pg/mL. Conclusion There are close relations between plasma NT-proBNP concentrations increase and impaired cardiac diastolic function, systolic function and cardiac enlargement in Chinese people.

Corelation Between Plasma N-terminal ProBNP(NT-proBNP) and Cardiac Dysfunction